
Sign up to save your podcasts
Or


The UK Investor Magazine was thrilled to welcome Alan Green back to the Podcast to discuss a selection of UK shares and the macroeconomic backdrop.
We discuss:
UK CPI inflation surprisingly fell to 6.7% in the year to August from 6.8% the month before. Expectations were for CPI read of 7%. We explore the consequences for housebuilding shares and the wider FTSE 250.
Avacta made a landmark announcement yesterday on the clinical trials of their AVA6000 chemotherapy drug. Alan breaks the release down and what to look for in the coming weeks from Avacta.
We finish with a look at the recent developments at ECR Minerals.
Hosted on Acast. See acast.com/privacy for more information.
By UK Investor Magazine5
22 ratings
The UK Investor Magazine was thrilled to welcome Alan Green back to the Podcast to discuss a selection of UK shares and the macroeconomic backdrop.
We discuss:
UK CPI inflation surprisingly fell to 6.7% in the year to August from 6.8% the month before. Expectations were for CPI read of 7%. We explore the consequences for housebuilding shares and the wider FTSE 250.
Avacta made a landmark announcement yesterday on the clinical trials of their AVA6000 chemotherapy drug. Alan breaks the release down and what to look for in the coming weeks from Avacta.
We finish with a look at the recent developments at ECR Minerals.
Hosted on Acast. See acast.com/privacy for more information.

42 Listeners

13 Listeners

43 Listeners

96 Listeners

62 Listeners

14 Listeners

5 Listeners

12 Listeners

12 Listeners

5 Listeners

2 Listeners

49 Listeners

10 Listeners

37 Listeners

2 Listeners